Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles

Ziaur Rehman Tanoli; Zaid Alam; Markus Vähä-Koskela; Balaguru Ravikumar; Alina Malyutina; Alok Jaiswal; Jing Tang; Krister Wennerberg; Tero Aittokallio

doi:10.1093/database/bay083

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles

Ziaur Rehman Tanoli^*, Zaid Alam, Markus Vähä-Koskela, Balaguru Ravikumar, Alina Malyutina, Alok Jaiswal, Jing Tang, Krister Wennerberg, Tero Aittokallio

^*Corresponding author for this work

16 Citations (Scopus)

62 Downloads (Pure)

Abstract

Drug Target Commons (DTC) is a web platform (database with user interface) for community-driven bioactivity data integration and standardization for comprehensive mapping, reuse and analysis of compound-target interaction profiles. End users can search, upload, edit, annotate and export expert-curated bioactivity data for further analysis, using an application programmable interface, database dump or tab-delimited text download options. To guide chemical biology and drug-repurposing applications, DTC version 2.0 includes updated clinical development information for the compounds and target gene-disease associations, as well as cancer-type indications for mutant protein targets, which are critical for precision oncology developments.

Original language	English
Article number	bay083
Journal	Database: The Journal of Biological Databases and Curation
Volume	2018
Issue number	2018
Pages (from-to)	1-13
Number of pages	13
ISSN	1758-0463
DOIs	https://doi.org/10.1093/database/bay083
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/database/bay083Licence: CC BY

Drug Target Commons 2.0: a community platform for systematic analysis of drug – target interaction profilesFinal published version, 15.3 MBLicence: CC BY

Cite this

Tanoli, Z. R., Alam, Z., Vähä-Koskela, M., Ravikumar, B., Malyutina, A., Jaiswal, A., Tang, J., Wennerberg, K., & Aittokallio, T. (2018). Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles. Database: The Journal of Biological Databases and Curation, 2018(2018), 1-13. [bay083]. https://doi.org/10.1093/database/bay083

Drug Target Commons 2.0 : a community platform for systematic analysis of drug-target interaction profiles. / Tanoli, Ziaur Rehman; Alam, Zaid; Vähä-Koskela, Markus et al.

In: Database: The Journal of Biological Databases and Curation, Vol. 2018, No. 2018, bay083, 2018, p. 1-13.

Research output: Contribution to journal › Journal article › Research › peer-review

Tanoli, ZR, Alam, Z, Vähä-Koskela, M, Ravikumar, B, Malyutina, A, Jaiswal, A, Tang, J, Wennerberg, K & Aittokallio, T 2018, 'Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles', Database: The Journal of Biological Databases and Curation, vol. 2018, no. 2018, bay083, pp. 1-13. https://doi.org/10.1093/database/bay083

@article{6f1ba5831ae24c5385e0c89ca2d81339,

title = "Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles",

abstract = "Drug Target Commons (DTC) is a web platform (database with user interface) for community-driven bioactivity data integration and standardization for comprehensive mapping, reuse and analysis of compound-target interaction profiles. End users can search, upload, edit, annotate and export expert-curated bioactivity data for further analysis, using an application programmable interface, database dump or tab-delimited text download options. To guide chemical biology and drug-repurposing applications, DTC version 2.0 includes updated clinical development information for the compounds and target gene-disease associations, as well as cancer-type indications for mutant protein targets, which are critical for precision oncology developments.",

author = "Tanoli, {Ziaur Rehman} and Zaid Alam and Markus V{\"a}h{\"a}-Koskela and Balaguru Ravikumar and Alina Malyutina and Alok Jaiswal and Jing Tang and Krister Wennerberg and Tero Aittokallio",

year = "2018",

doi = "10.1093/database/bay083",

language = "English",

volume = "2018",

pages = "1--13",

journal = "Database : the journal of biological databases and curation",

issn = "1758-0463",

publisher = "Oxford University Press",

number = "2018",

}

TY - JOUR

T1 - Drug Target Commons 2.0

T2 - a community platform for systematic analysis of drug-target interaction profiles

AU - Tanoli, Ziaur Rehman

AU - Alam, Zaid

AU - Vähä-Koskela, Markus

AU - Ravikumar, Balaguru

AU - Malyutina, Alina

AU - Jaiswal, Alok

AU - Tang, Jing

AU - Wennerberg, Krister

AU - Aittokallio, Tero

PY - 2018

Y1 - 2018

N2 - Drug Target Commons (DTC) is a web platform (database with user interface) for community-driven bioactivity data integration and standardization for comprehensive mapping, reuse and analysis of compound-target interaction profiles. End users can search, upload, edit, annotate and export expert-curated bioactivity data for further analysis, using an application programmable interface, database dump or tab-delimited text download options. To guide chemical biology and drug-repurposing applications, DTC version 2.0 includes updated clinical development information for the compounds and target gene-disease associations, as well as cancer-type indications for mutant protein targets, which are critical for precision oncology developments.

AB - Drug Target Commons (DTC) is a web platform (database with user interface) for community-driven bioactivity data integration and standardization for comprehensive mapping, reuse and analysis of compound-target interaction profiles. End users can search, upload, edit, annotate and export expert-curated bioactivity data for further analysis, using an application programmable interface, database dump or tab-delimited text download options. To guide chemical biology and drug-repurposing applications, DTC version 2.0 includes updated clinical development information for the compounds and target gene-disease associations, as well as cancer-type indications for mutant protein targets, which are critical for precision oncology developments.

U2 - 10.1093/database/bay083

DO - 10.1093/database/bay083

M3 - Journal article

C2 - 30219839

AN - SCOPUS:85057340460

SN - 1758-0463

VL - 2018

SP - 1

EP - 13

JO - Database : the journal of biological databases and curation

JF - Database : the journal of biological databases and curation

IS - 2018

M1 - bay083

ER -

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this